Clinical Trials on Dyslipidaemias
Total 2796 results
-
GlaxoSmithKlineCompletedDyslipidaemia | DyslipidaemiasGermany, Estonia, Belgium, France, Netherlands, Denmark, Portugal, Norway, Sweden, Lithuania, Finland
-
GlaxoSmithKlineCompletedHealthy Subjects | Dyslipidaemia | DyslipidaemiasUnited Kingdom
-
GlaxoSmithKlineCompletedDyslipidemias | DyslipidaemiasUnited States
-
GlaxoSmithKlineCompletedDyslipidaemiasUnited States, Canada
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
Xention LtdCompleted
-
AstraZenecaCompletedDyslipidaemiaCzech Republic
-
GlaxoSmithKlineCompletedHealthy Subjects | DyslipidaemiasUnited States
-
AstraZenecaCompleted
-
Novartis PharmaceuticalsCompletedDyslipidaemiaJordan, United States, Taiwan
-
GlaxoSmithKlineCompletedHealthy Subjects | DyslipidaemiasUnited States
-
Novo Nordisk A/SRecruitingHealthy Volunteers | DyslipidaemiaUnited States
-
AstraZenecaCompletedDyslipidaemiaRussian Federation
-
AstraZenecaCompletedHypercholesterolemia | Dyslipidaemia
-
AstraZenecaCompletedHypercholesterolemia | Dyslipidaemia
-
AstraZenecaCompletedDyslipidaemiaRussian Federation
-
Xention LtdCompleted
-
AstraZenecaCompletedHypercholesterolemia | Dyslipidaemia
-
AstraZenecaCompletedFredrickson Type IIa & Type IIb Dyslipidaemia
-
NeuroBo Pharmaceuticals Inc.CompletedSevere Hypertriglyceridemia | Mixed DyslipidaemiaUnited States, Canada
-
GlaxoSmithKlineCompletedHealthy Subjects | DyslipidaemiasUnited States
-
GlaxoSmithKlineCompletedAn Exploratory Study To Look At The Effect Of Two Investigational Drugs On Body Fat And InflammationObesity | Hypercholesterolemia | DyslipidaemiasUnited States
-
GlaxoSmithKlineTerminatedHeart Failure | DyslipidaemiasUnited States
-
University Health Network, TorontoCanadian Institutes of Health Research (CIHR)CompletedInsulin Resistance | DyslipidaemiaCanada
-
GenfitCompletedAbdominal Obesity | Atherogenic DyslipidaemiaFrance, Romania, Tunisia
-
IlDong Pharmaceutical Co LtdCompletedMixed DyslipidemiasKorea, Republic of
-
Hanlim Pharm. Co., Ltd.RecruitingMixed DyslipidemiaKorea, Republic of
-
IlDong Pharmaceutical Co LtdNot yet recruiting
-
Arrowhead PharmaceuticalsCompletedMixed DyslipidemiaUnited States, Australia, Poland, New Zealand, Canada, Hungary
-
Provident Clinical ResearchReliant PharmaceuticalsCompleted
-
GWT-TUD GmbHTechnische Universität Dresden; University of RegensburgCompletedMetabolic Syndrome | DyslipidaemiaGermany
-
Arrowhead PharmaceuticalsActive, not recruitingMixed DyslipidemiaUnited States, Australia, Canada, New Zealand
-
Yooyoung Pharmaceutical Co., Ltd.CompletedCombined DyslipidemiaKorea, Republic of
-
Société des Produits Nestlé (SPN)CompletedPrimary DyslipidemiaChina
-
Provident Clinical ResearchReliant PharmaceuticalsUnknown
-
Addpharma Inc.Recruiting
-
University of GuadalajaraCompleted
-
Esperion Therapeutics, Inc.CompletedMild DyslipidemiaUnited States
-
Hanlim Pharm. Co., Ltd.Completed
-
AbbottCompletedMixed DyslipidemiaUnited States
-
Kowa Research Institute, Inc.CompletedMixed Dyslipidemia | Primary DyslipidemiaUnited States
-
SanofiCompletedAtherosclerotic Cardiovascular Disease | Primary Hypercholesterolaemia and Mixed DyslipidaemiaGermany
-
Chong Kun Dang PharmaceuticalCompletedDyslipidemia (Fredrickson Type Ⅱa) | Dyslipidemia (Fredrickson Type Ⅱb)Korea, Republic of
-
Hospital Universitario Reina Sofia de CordobaSpanish Society of Family and Community MedicineCompletedPatients With DyslipidemiaSpain
-
AstraZenecaCompletedPatients With DyslipidemiaBrazil
-
Chong Kun Dang PharmaceuticalCompletedHypertensive Patients With DyslipidemiaKorea, Republic of
-
Merck Sharp & Dohme LLCTerminatedHypercholesterolemia | Mixed Dyslipidemia